Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Evotec, Asahi Kasei Enter Drug Discovery Collaboration | Contract Pharma

What are you searching for?

Sign in
Collaborations & Alliances

Evotec, Asahi Kasei Enter Drug Discovery Collaboration

Evotec will apply its integrated drug discovery platform to optimize hit compounds

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Evotec AG has entered into a drug discovery collaboration with Asahi Kasei Pharma Corp. for an ion channel target. Financial details were not disclosed.

Evotec will apply its integrated drug discovery platform including medicinal chemistry, computational chemistry and in vitro pharmacology to optimize hit compounds identified and selected from the Evotec compound library through a recent successful high-throughput screening campaign executed at Evotec.

Dr. Mario Polywka, chief operating officer of Evotec, said, “We are delighted to expand our collaboration with Asahi Kasei Pharma into a fully integrated drug discovery project. Evotec operates one of the most comprehensive ion channel platforms in the industry and this collaboration represents further validation of the strength of this platform and the library screened. We look forward to working closely with our colleagues at Asahi Kasei Pharma.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics